LifeMD (LFMD) Cash & Current Investments (2012 - 2025)

LifeMD's Cash & Current Investments history runs 14 years deep, the most recent figure standing at $37.1 million for Q4 2025.

• Quarterly Cash & Current Investments rose 13.54% year-over-year to $37.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $37.1 million (up 13.54% YoY) and the FY2025 annual result came in at $37.1 million, up 13.54% from the prior year.
• Cash & Current Investments was $37.1 million for Q4 2025 at LifeMD, up from $24.2 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $41.5 million in Q4 2021 and bottomed at $1.4 million in Q2 2021.
• A 5-year average of $23.1 million and a median of $24.9 million in 2022 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2021 — Cash & Current Investments soared 4984.89% — and 2022, when it plunged 90.16%.
• LifeMD's Cash & Current Investments stood at $41.5 million in 2021, then plunged by 90.16% to $4.1 million in 2022, then surged by 723.13% to $33.6 million in 2023, then decreased by 2.8% to $32.7 million in 2024, then climbed by 13.54% to $37.1 million in 2025.
• Business Quant data shows LFMD's Cash & Current Investments at $37.1 million in Q4 2025, $24.2 million in Q3 2025, and $36.5 million in Q2 2025.